Analysis of 13,472 Cases of Adverse Drug Reaction/Event of
Ceftriaxone Sodium for Injection

Asina Journal Of Social Pharmacy

Previous Articles Next Articles

Analysis of 13,472 Cases of Adverse Drug Reaction/Event of Ceftriaxone Sodium for Injection

Wei Fenfang, Zheng Yongxia, Yang Yue*

School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China

Online:2017-03-20 Published:2017-05-05
Contact: Yang Yue, professor. Major research area: regulatory affairs and drug policy, etc. Tel: 024-23986372, E-mail: yyue315@vip.126.com.

Abstract

Abstract: Objective To make a descriptive analysis of the adverse drug reaction reports of ceftriaxone sodium for injection collected from a provincial spontaneous reporting system (SRS) and to find out its potential risks in clinical use. Methods Retrospective and descriptive methods were used to analyze 13,472 cases of adverse drug reaction/event (ADR/ADE) of ceftriaxone sodium for injection collected from January 1, 2004 to December 31, 2013. Results and Conclusion The clinical use of ceftriaxone sodium for injection shows the risks, including off-label use, overdose, and incompatibility. Therefore, supervision of clinical use of ceftriaxone sodium for injection should be strengthened so as to reduce the incidence of clinical ADR/ADE.

Key words: ceftriaxone sodium for injection, adverse reaction, risk

Wei Fenfang, Zheng Yongxia, Yang Yue. Analysis of 13,472 Cases of Adverse Drug Reaction/Event of Ceftriaxone Sodium for Injection [J]. Asina Journal Of Social Pharmacy.

Trendmd

[1]	Wang Jinping, Sheng Qi, Zhao Jie, Wu Zhiang. Analysis of the Incidence and Risk Factors of Postoperative Infection in Patients with Class I Incisions Based on Literature Research [J]. Asian Journal of Social Pharmacy, 2024, 19(4): 383-389.
[2]	Diao Yuanyuan, Wu Zhiang. Identifying and Managing Technical Risks in the Process of Innovative Drugs Development in China [J]. Asian Journal of Social Pharmacy, 2024, 19(2): 126-134.
[3]	Diao Yuanyuan, Wu Zhiang. Analytic Hierarchy Process for Technological Risks in the Process of Innovative Drug Development in China [J]. Asian Journal of Social Pharmacy, 2024, 19(1): 29-42.
[4]	Li Zhuangqi, Yang Yue. Benefit-Risk Assessment for PD-1/PD-L1 Inhibitors in the Treatment of Non-Small Cell Lung Cancer [J]. Asian Journal of Social Pharmacy, 2022, 17(3): 253-259.
[5]	Xu Wenxiu, Ma Hui, Yang Dianzheng, Wei Jing. Study on the Application of Quality Risk Management on Drug Collinear Production [J]. Asian Journal of Social Pharmacy, 2022, 17(1): 39-49.
[6]	Yang Luyao, Dong Jiangping, Yang Yue. Research of FDA Risk-Based Drug Inspection Program and Its Enlightenment [J]. Asian Journal of Social Pharmacy, 2021, 16(2): 114-119.
[7]	Yang Yu, Shi Yu, Hu Rongbo, Tian Lijuan. Research and Enlightenment of EU Drug Risk Management Plan [J]. Asian Journal of Social Pharmacy, 2021, 16(1): 23-30.
[8]	Zhang Zhan, Xue Aoming, Zhang Fang. Research on Risk Identification of Supply Chain Management in Pharmaceutical Wholesale Enterprises——Taking Enterprise A as an Example [J]. Asian Journal of Social Pharmacy, 2020, 15(4): 237-242.
[9]	Tang Ying, Chen Yuwen. Risk Control Strategy in the Research and Development of Pediatric Drugs [J]. Asian Journal of Social Pharmacy, 2019, 14(3): 110-118.
[10]	Zhao Jianfeng, Zhang Wei, Yu Hai. Reflections on the Management of Preventing Interest Conflict among Pharmacopoeia Members [J]. Asina Journal Of Social Pharmacy, 2019, 14(2): 39-44.
[11]	Jin Quanyuan, Lin Xiaohui, Dong Li. Research on Setting up Patent Risk Management System in Medical colleges and universities in China [J]. Asina Journal Of Social Pharmacy, 2018, 13(1): 8-15.
[12]	. Research on Promoting Effectiveness of Supplier on-site Audit [J]. Asina Journal Of Social Pharmacy, 2017, 12(4): 140-143.
[13]	Wei Fenfang, Zhang Zhongyi, Zheng Yongxia, Yang Yue. Analysis of 4,562 Cases of Adverse Drug Reaction/Event Caused by Cefoperazone Sodium and Sulbactam Sodium for Injection [J]. Asina Journal Of Social Pharmacy, 2016, 11(4): 135-143.
[14]	. The Application of HACCP System in Drug Distribution [J]. Asina Journal Of Social Pharmacy, 2016, 11(1): 37-41.
[15]	YANG Na;CHEN Yu-wen. Risk Reviews of Preclinical Pharmaceutical Studieson Traditional Chinese Medicine Injection [J]. , 2015, 10(3): 143-148.

Asian Journal Of Social Pharmacy

Analysis of 13,472 Cases of Adverse Drug Reaction/Event of Ceftriaxone Sodium for Injection

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments